Trial Profile
A Multicentre, Open-label, Pharmacokinetic Study of Modigraf (Tacrolimus Granules) in de Novo Paediatric Allograft Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jun 2019
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Allotransplant rejection; Heart transplant rejection; Liver transplant rejection; Renal transplant rejection
- Focus Pharmacokinetics
- Acronyms OPTION
- Sponsors Astellas Pharma; Astellas Pharma Europe Ltd
- 01 Feb 2019 Results published in the Pediatric Transplantation
- 22 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Dec 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2014 to 1 Sep 2015.